← All organizations

Hisamitsu Pharmaceutical Co., Inc.

For profitContributed to NMEWebsite ↗

Also known as: Hisamitsu | HISAMITSU | Hisamitsu Farmaceutica do Brasil Ltda | HISAMITSU PHARM CO

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Mar 22, 2022

Timeline

1840s

Jun 1, 1847
Hisamitsu Pharmaceutical Co., Inc.— Founded

2000s

Feb 20, 2008
menthol— NDA Organization
Jul 14, 2009
Noven Therapeutics— Acquired

2010s

Oct 11, 2019
asenapine— Marketing Organization
Oct 11, 2019
asenapine— NDA Secondary Org

Drugs by trial phase (11 distinct, 27 trials)

Phase 4 (0 own, 1 via acquisition)

methylphenidate

Phase 3 (2 own, 4 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Phase 1 (0 own, 2 via acquisition)

Marketed drugs (7)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (11)

NCT01400594Lead sponsorPhase 2Jul 1, 2011
NCT00970658Lead sponsorPhase 3Dec 1, 2009
NCT00927641Lead sponsorPhase 3Jul 1, 2009
NCT00680784Lead sponsorPhase 3Apr 1, 2008
NCT00680472Lead sponsorPhase 3Apr 1, 2008
NCT00680784Study directorPhase 3Apr 1, 2008
NCT00680472Study directorPhase 3Apr 1, 2008
NCT00647231Study directorPhase 2Mar 1, 2008
NCT00647231Lead sponsorPhase 2Mar 1, 2008
NCT00792727Lead sponsorPhase 3Sep 1, 2007
NCT00792727Study directorPhase 3Sep 1, 2007

Details

Founded: Tosu, JP Jun 1, 1847
First NDA: Feb 20, 2008
Last known activity: Mar 22, 2022